Skip to main content
Log in

A whole-genome sequencing–based novel preimplantation genetic testing method for de novo mutations combined with chromosomal balanced translocations

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To explore a new preimplantation genetic testing (PGT) method for de novo mutations (DNMs) combined with chromosomal balanced translocations by whole-genome sequencing (WGS) using the MGISEQ-2000 sequencer.

Methods

Two families, one with maternal Olmsted syndrome caused by DNM (c.1246C>T) in TRPV3 and a paternal Robertsonian translocation and one with paternal Marfan syndrome caused by DNM (c.4952_4955delAATG) in FBN1 and a maternal reciprocal translocation, underwent PGT for monogenetic disease (PGT-M), chromosomal aneuploidy, and structural rearrangement. WGS of embryos and family members were performed. Bioinformatics analysis based on gradient sequencing depth was performed, and parent-embryo haplotyping was conducted for DNM diagnosis. Sanger sequencing, karyotyping, and chromosomal microarray analysis were performed using an amniotic fluid sample to confirm the PGT results.

Results

After 1 PGT cycle, WGS of 2 embryos from the Olmsted syndrome family revealed euploid embryos without DNMs; after 2 cycles, the 11 embryos from the Marfan syndrome family showed only 1 normal embryo without DNM, copy number variations (CNVs), or aneuploidy. Moreover, 1 blastocyst from the Marfan syndrome family was transferred back to the uterus; the amniocentesis test results were confirmed by PGT and a healthy infant was born.

Conclusions

WGS based on parent-embryo haplotypes was an effective strategy for PGT of DNMs combined with a chromosomal balanced translocation. Our results indicate this is a reliable and effective diagnostic method that is useful for clinical application in PGT of patients with DNMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet. 2012;13:565–75.

    Article  CAS  Google Scholar 

  2. Mao R, McDonald J, Cantwell M, Tang W, Ward K. The implication of de novo 21-hydroxylase mutation in clinical and prenatal molecular diagnoses. Genet Test. 2005;9:121–5.

    Article  CAS  Google Scholar 

  3. Harton GL, De Rycke M, Fiorentino F, Moutou C, SenGupta S, Traeger-Synodinos J, et al. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod. 2011;26:33–40.

    Article  CAS  Google Scholar 

  4. Altarescu G, Eldar-Geva T, Varshower I, Brooks B, Haran EZ, Margalioth EJ, et al. Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Hum Reprod. 2009;24:3225–9.

    Article  CAS  Google Scholar 

  5. Chen L, Diao Z, Xu Z, Zhou J, Yan G, Sun H. The clinical application of single-sperm-based SNP haplotyping for PGD of osteogenesis imperfecta. Syst Biol Reprod Med. 2019;65:75–80.

    Article  CAS  Google Scholar 

  6. Rechitsky S, Pomerantseva E, Pakhalchuk T, Pauling D, Verlinsky O, Kuliev A. First systematic experience of preimplantation genetic diagnosis for de-novo mutations. Reprod BioMed Online. 2011;22:350–61.

    Article  Google Scholar 

  7. Fiorentino F, Bono S, Biricik A, Nuccitelli A, Cotroneo E, Cottone G, et al. Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles. Hum Reprod. 2014;29:2802–13.

    Article  CAS  Google Scholar 

  8. Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47:651–8.

    Article  Google Scholar 

  9. Wang S, Niu Z, Wang H, Ma M, Zhang W, Fang Wang S, et al. De novo paternal FBN1 mutation detected in embryos before implantation. Med Sci Monit. 2017;23:3136–46.

    Article  Google Scholar 

  10. Yan L, Huang L, Xu L, Huang J, Ma F, Zhu X, et al. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses. Proc Natl Acad Sci U S A. 2015;112:15964–9.

    Article  CAS  Google Scholar 

  11. Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. In: Jansen R, Mortimer D, editors. Toward reproductive certainty: fertility and genetics beyond 1999. London: Parthenon Publishing; 1999. p. 378–88.

    Google Scholar 

  12. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307–11.

    Article  CAS  Google Scholar 

  13. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod. 2011;26:41–6.

    Article  CAS  Google Scholar 

  14. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564–9.

    Article  CAS  Google Scholar 

  15. Yin X, Tan K, Vajta G, Jiang H, Tan Y, et al. Massively parallel sequencing for chromosomal abnormality testing in trophectoderm cells of human blastocysts. Biol Reprod. 2013;88:69.

    Article  CAS  Google Scholar 

  16. Giménez C, Sarasa J, Arjona C, Vilamajó E, Martínez-Pasarell O, Wheeler K, et al. Karyomapping allows preimplantation genetic diagnosis of a de-novo deletion undetectable using conventional PGD technology. Reprod BioMed Online. 2015;31:770–5.

    Article  Google Scholar 

  17. Spits C, Le Caignec C, De Rycke M, Van Haute L, Van Steirteghem A, Liebaers I, et al. Whole-genome multiple displacement amplification from single cells. Nat Protoc. 2006;1:1965–70.

    Article  CAS  Google Scholar 

  18. Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell. 2012;148:873–85.

    Article  CAS  Google Scholar 

  19. Peters BA, Kermani BG, Alferov O, Agarwal MR, McElwain MA, Gulbahce N, et al. Detection and phasing of single base de novo mutations in biopsies from human in vitro fertilized embryos by advanced whole-genome sequencing. Genome Res. 2015;25:426–34.

    Article  CAS  Google Scholar 

  20. Masset H, Zamani Esteki M, Dimitriadou E, Dreesen J, Debrock S, Derhaag J, et al. Multi-Centre evaluation of a comprehensive preimplantation genetic test through haplotyping-by-sequencing. Hum Reprod. 2019;34:1608–19.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank all patients and their family members for their participation in this study.

Funding

This work was partially supported by the National Natural Science Foundation of China (No. 81801431), the Chinese Medical Association clinical medical research special fund, Research and development of young physicians in reproductive medicine (No. 18010060735), the Shenzhen Birth Defect Screening Project Lab (JZF No. [2016] 750), and the Shenzhen Municipal Government of China (No. JCYJ20170412152854656).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Fang Chen or Wenjun Wang.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Fig. S1

Sanger sequencing results of the Olmsted syndrome family, their 2 embryos, and related the first polar body (PB1) and the second polar body (PB2) for detecting maternal missense mutation (c.1246C > T) in the TRPV3 gene. (PNG 134 kb)

High resolution image (TIF 200 kb)

Figure S2

Sanger sequencing results of the Marfan syndrome family and their 11 embryos for detecting paternal frameshift mutation (c.4952_4955delAATG) in the FBN1 gene. (PNG 221 kb)

High resolution image (TIF 346 kb)

Fig. S3

Validations of the fetus in the Marfan syndrome family. (a) Sanger sequencing of the amniotic fluid cells confirms that the baby does not have the mutant allele in TRPV3. (b) Chromosomal karyotype analysis reveals that the fetus has the same karyotype as the mother who carries the chromosomal reciprocal translocation (46, XN, t (10; 20) (q26.1; q13.1)). (c) Single nucleotide polymorphism (SNP) array for the detection of copy number variations (CNVs) and aneuploidy shows that the fetus has no chromosomal abnormalities. (PNG 3208 kb)

High resolution image (TIF 3738 kb)

ESM 4

(DOCX 14 kb)

ESM 5

(DOCX 16 kb)

ESM 6

(DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, P., Xia, J., Ou, S. et al. A whole-genome sequencing–based novel preimplantation genetic testing method for de novo mutations combined with chromosomal balanced translocations. J Assist Reprod Genet 37, 2525–2533 (2020). https://doi.org/10.1007/s10815-020-01921-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-020-01921-4

Keywords

Navigation